AI assistant
GlaxoSmithKline PLC — Director's Dealing 2014
Jul 11, 2014
5262_dirs_2014-07-11_6f724de1-ab0c-4f31-9efc-2e4b45afe72a.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1582M
GlaxoSmithKline PLC
11 July 2014
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors or Persons Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary Shares at a price of 1561.76 pence per Ordinary Share on 10 July 2014 as a result of the reinvestment of dividends paid on Ordinary Shares held in the GlaxoSmithKline ShareReward Plan (the Plan).
| Sir Andrew Witty | Acquisition of 31 Ordinary Shares |
| Mr S Dingemans | Acquisition of 9 Ordinary Shares |
| Mr S M Bicknell | Acquisition of 45 Ordinary Shares |
| Mr R G Connor | Acquisition of 39 Ordinary Shares |
| Mr S A Hussain | Acquisition of 8 Ordinary Shares |
| Mr D S Redfern | Acquisition of 45 Ordinary Shares |
| Ms C Thomas | Acquisition of 45 Ordinary Shares |
| Mr P C Thomson | Acquisition of 22 Ordinary Shares |
| Dr P J T Vallance | Acquisition of 24 Ordinary Shares |
| Ms E Walmsley | Acquisition of 5 Ordinary Shares |
| Mrs V A Whyte | Acquisition of 31 Ordinary Shares |
The Company and the above-mentioned persons were advised of this information on
11 July 2014.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
11 July 2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSQFLFFZDFBBBX